Gut metabolites and breast cancer: the continuum of dysbiosis, breast cancer risk, and potential breast cancer therapy

HIGHLIGHTS

• who: Kayla Jaye and colleagues from the NICM Health Research Institute, Western Sydney University, Penrith, NSW, Australia have published the Article: Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy, in the Journal: Gut microbiota is the collective term for microorganisms residing within the human gut and they interact with the host immune system both directly and indirectly to contribute to gut homeostasis and fight infection [1]. The metabolic by-products of gut microbiota, gut metabolites have demonstrated a close interrelationship with the host in the inhibition of different . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.